Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126070121 | 12607012 | 1 | I | 20160615 | 20160725 | 20160729 | 20160729 | EXP | DE-PFIZER INC-2016360304 | PFIZER | 47.00 | YR | F | Y | 73.00000 | KG | 20160729 | CN | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126070121 | 12607012 | 1 | PS | VENLAFAXINE HCL | VENLAFAXINE HYDROCHLORIDE | 1 | 37.5 MG, UNK | U | 20699 | 37.5 | MG | PROLONGED-RELEASE CAPSULE | |||||||
| 126070121 | 12607012 | 2 | SS | VENLAFAXINE HCL | VENLAFAXINE HYDROCHLORIDE | 1 | 187.5 MG, UNK | U | 20699 | 187.5 | MG | PROLONGED-RELEASE CAPSULE | |||||||
| 126070121 | 12607012 | 3 | SS | VENLAFAXINE HCL | VENLAFAXINE HYDROCHLORIDE | 1 | 150 MG, UNK | U | 20699 | 150 | MG | PROLONGED-RELEASE CAPSULE | |||||||
| 126070121 | 12607012 | 4 | SS | VENLAFAXINE HCL | VENLAFAXINE HYDROCHLORIDE | 1 | 112.5 MG, UNK | U | 20699 | 112.5 | MG | PROLONGED-RELEASE CAPSULE | |||||||
| 126070121 | 12607012 | 5 | SS | VENLAFAXINE HCL | VENLAFAXINE HYDROCHLORIDE | 1 | 75 MG, UNK | U | 20699 | 75 | MG | PROLONGED-RELEASE CAPSULE | |||||||
| 126070121 | 12607012 | 6 | SS | VENLAFAXINE HCL | VENLAFAXINE HYDROCHLORIDE | 1 | 37.5 MG, UNK | U | 20699 | 37.5 | MG | PROLONGED-RELEASE CAPSULE | |||||||
| 126070121 | 12607012 | 7 | C | L-THYROXIN | LEVOTHYROXINE SODIUM | 1 | 75 MG, DAILY | 0 | 75 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126070121 | 12607012 | 1 | Depression |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126070121 | 12607012 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126070121 | 12607012 | Blood glucose increased | |
| 126070121 | 12607012 | Decreased appetite | |
| 126070121 | 12607012 | Diarrhoea | |
| 126070121 | 12607012 | Drug withdrawal syndrome | |
| 126070121 | 12607012 | Dysaesthesia | |
| 126070121 | 12607012 | Ear discomfort | |
| 126070121 | 12607012 | Eructation | |
| 126070121 | 12607012 | Fatigue | |
| 126070121 | 12607012 | Feeling abnormal | |
| 126070121 | 12607012 | Gait disturbance | |
| 126070121 | 12607012 | Haematochezia | |
| 126070121 | 12607012 | Hyperhidrosis | |
| 126070121 | 12607012 | Hypotonia | |
| 126070121 | 12607012 | Labile blood pressure | |
| 126070121 | 12607012 | Middle insomnia | |
| 126070121 | 12607012 | Muscle twitching | |
| 126070121 | 12607012 | Nausea | |
| 126070121 | 12607012 | Occult blood positive | |
| 126070121 | 12607012 | Palpitations | |
| 126070121 | 12607012 | Restless legs syndrome | |
| 126070121 | 12607012 | Tension | |
| 126070121 | 12607012 | Tremor | |
| 126070121 | 12607012 | Vision blurred | |
| 126070121 | 12607012 | Weight bearing difficulty | |
| 126070121 | 12607012 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126070121 | 12607012 | 1 | 2012 | 0 | ||
| 126070121 | 12607012 | 2 | 201512 | 201602 | 0 | |
| 126070121 | 12607012 | 3 | 201602 | 201603 | 0 | |
| 126070121 | 12607012 | 4 | 201603 | 201604 | 0 | |
| 126070121 | 12607012 | 5 | 201604 | 2016 | 0 | |
| 126070121 | 12607012 | 6 | 2016 | 0 |